1. Home
  2. NVCR vs FIGS Comparison

NVCR vs FIGS Comparison

Compare NVCR & FIGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • FIGS
  • Stock Information
  • Founded
  • NVCR 2000
  • FIGS 2013
  • Country
  • NVCR Switzerland
  • FIGS United States
  • Employees
  • NVCR N/A
  • FIGS N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • FIGS Apparel
  • Sector
  • NVCR Health Care
  • FIGS Consumer Discretionary
  • Exchange
  • NVCR Nasdaq
  • FIGS Nasdaq
  • Market Cap
  • NVCR 1.4B
  • FIGS 1.1B
  • IPO Year
  • NVCR 2015
  • FIGS 2021
  • Fundamental
  • Price
  • NVCR $12.15
  • FIGS $7.08
  • Analyst Decision
  • NVCR Buy
  • FIGS Sell
  • Analyst Count
  • NVCR 7
  • FIGS 4
  • Target Price
  • NVCR $28.79
  • FIGS $5.38
  • AVG Volume (30 Days)
  • NVCR 1.3M
  • FIGS 1.9M
  • Earning Date
  • NVCR 10-29-2025
  • FIGS 11-06-2025
  • Dividend Yield
  • NVCR N/A
  • FIGS N/A
  • EPS Growth
  • NVCR N/A
  • FIGS N/A
  • EPS
  • NVCR N/A
  • FIGS 0.04
  • Revenue
  • NVCR $630,160,000.00
  • FIGS $569,581,000.00
  • Revenue This Year
  • NVCR $6.68
  • FIGS $4.63
  • Revenue Next Year
  • NVCR $7.01
  • FIGS $3.69
  • P/E Ratio
  • NVCR N/A
  • FIGS $163.06
  • Revenue Growth
  • NVCR 14.58
  • FIGS 3.41
  • 52 Week Low
  • NVCR $10.87
  • FIGS $3.57
  • 52 Week High
  • NVCR $34.13
  • FIGS $7.31
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 46.57
  • FIGS 56.41
  • Support Level
  • NVCR $11.98
  • FIGS $6.59
  • Resistance Level
  • NVCR $12.83
  • FIGS $7.31
  • Average True Range (ATR)
  • NVCR 0.56
  • FIGS 0.26
  • MACD
  • NVCR 0.15
  • FIGS -0.01
  • Stochastic Oscillator
  • NVCR 25.49
  • FIGS 71.78

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About FIGS FIGS Inc.

FIGS Inc is a healthcare apparel company. The Company designs and sells scrubwear and non-scrubwear, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear and other apparel. The Company generates maximum revenue from United States. Sales are generated through the Company's digital platforms.

Share on Social Networks: